Is Retuxima a Good Treatment for Miasenia?

You have to be careful and nuanced about the recommendation, absolutely, especially in rare disease it where you're not likely to get multiple prospective trials exactly. Eclis mab is another story. It's a really exciting drug. It has a novel mechanism of action, as you know, it inhibits complement. And again, fa to achieve the primary outcome of steroid sparing, we now have an even softer recommendation for methodricate use.